Adverse pregnancy outcomes and cardiovascular risk factor management

Seminars in Perinatology

Volumn 39, Issue 4, 2015, Pages 268-275

  Mehta, Puja K ^a   Minissian, Margo ^a   Bairey Merz, C Noel ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Gestational diabetes; Pre eclampsia; Women

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADVERSE OUTCOME; CARDIOVASCULAR RISK; ETHNICITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LACTATION; MATERNAL HYPERTENSION; MATERNAL NUTRITION; OBESITY; PHYSICAL ACTIVITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; TOBACCO USE; ADULT; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; COMPLICATION; EPIDEMIOLOGY; FEMALE; MORTALITY; NEWBORN; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRIMARY PREVENTION; RISK REDUCTION; UNITED STATES; WEIGHT REDUCTION; WOMEN'S HEALTH;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT, NEWBORN; OBESITY; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; UNITED STATES; WEIGHT LOSS; WOMEN'S HEALTH;

EID: 84937969916     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.05.005     Document Type: Review

References (74)

1. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129(3):e28-e292.
2. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011, 123(11):1243-1262.
3. Ford E.S., Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007, 50(22):2128-2132.
4. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2010. WONDER Online Database; 2013.
5. Clark A.M., DesMeules M., Luo W., Duncan A.S., Wielgosz A. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol 2009, 6(11):712-722.
6. Kaplan R.C., Aviles-Santa M.L., Parrinello C.M., et al. Body mass index, sex, and cardiovascular disease risk factors among hispanic/latino adults: Hispanic community health study/study of latinos. J Am Heart Assoc 2014, 3(4):e000923.
7. Mosca L., Hammond G., Mochari-Greenberger H., et al. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013, 127(11):1254-1263. [e1251-1229].
8. Mosca L., Mochari-Greenberger H., Dolor R.J., Newby L.K., Robb K.J. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes 2010, 3(2):120-127.
9. Ellrodt A.G., Fonarow G.C., Schwamm L.H., et al. Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes. Circulation 2013, 128(22):2447-2460.
10. Micieli G., Cavallini A., Quaglini S., Guideline Application for Decision Making in Ischemic Stroke Study Group Guideline compliance improves stroke outcome: a preliminary study in 4 districts in the Italian region of Lombardia. Stroke 2002, 33(5):1341-1347.
11. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2935-2959.
12. Stone N.J., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2889-2934.
13. Bateman B.T., Shaw K.M., Kuklina E.V., Callaghan W.M., Seely E.W., Hernandez-Diaz S. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PloS One 2012, 7(4):e36171.
14. U.S.Preventive Services Task Force Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007, 147(11):783-786.
15. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002, 106(3):388-391.
16. Pickering T.G., Hall J.E., Appel L.J., et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens 2005, 7(2):102-109.
17. Lenfant C., Chobanian A.V., Jones D.W., Roccella E.J., Joint National Committee on the Prevention DE, Treatment of High Blood Pressure Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003, 41(6):1178-1179.
18. James P.A., Oparil S., Carter B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 2014, 311(5):507-520.
19. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013, 122(5):1122-1131.
20. Buttar H.S. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997, 176(1-2):61-71.
21. Bushnell C., McCullough L.D., Awad I.A., et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45(5):1545-1588.
22. Lydakis C., Lip G.Y., Beevers M., Beevers D.G. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999, 12(6):541-547.
23. Podymow T., August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy 2010, 29(3):294-300.
24. Beardmore K.S., Morris J.M., Gallery E.D. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 2002, 21(1):85-95.
25. Ghanem F.A., Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther 2008, 26(1):38-49.
26. Shufelt C.L., Bairey Merz C.N. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009, 53(3):221-231.
27. Farley T.M., Meirik O., Chang C.L., Poulter N.R. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health 1998, 52(12):775-785.
28. MacClellan L.R., Giles W., Cole J., et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007, 38(9):2438-2445.
29. Mudd L.M., Holzman C.B., Catov J.M., Senagore P.K., Evans R.W. Maternal lipids at mid-pregnancy and the risk of preterm delivery. Acta Obstet Gynecol Scand 2012, 91(6):726-735.
30. Magnussen E.B., Vatten L.J., Lund-Nilsen T.I., Salvesen K.A., Davey Smith G., Romundstad P.R. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia. Br Med J 2007, 335(7627):978.
31. Catov J.M., Bodnar L.M., Kip K.E., et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007, 197(6):610.e1-610.e7. [United States].
32. Catov J.M., Bodnar L.M., Ness R.B., Barron S.J., Roberts J.M. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007, 166(11):1312-1319. [United States].
33. Bartels A., Egan N., Broadhurst D.I., et al. Maternal serum cholesterol levels are elevated from the 1st trimester of pregnancy: a cross-sectional study. J Obstet Gynaecol 2012, 32(8):747-752.
34. Hermes W., Franx A., van Pampus M.G., et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol 2013, 208(6):e471-e478. 474.
35. Hu G., Jousilahti P., Qiao Q., Peltonen M., Katoh S., Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005, 45(9):1413-1418.
36. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J 2006, 332(7533):73-78.
37. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011, 57(12):1404-1423. [United States].
38. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373(9677):1773-1779.
39. Yogev Y., Xenakis E.M., Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004, 191(5):1655-1660.
40. Wenger N.K. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol 2014, 113(2):406-409.
41. Carr D.B., Newton K.M., Utzschneider K.M., et al. Preeclampsia and risk of developing subsequent diabetes. Hypertens Pregnancy 2009, 28(4):435-447.
42. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(suppl 1):S5-S20.
43. Blumer I., Hadar E., Hadden D.R., et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013, 98(11):4227-4249.
44. Committee on Practice B-Obstetrics Practice Bulletin No. 137: gestational diabetes mellitus. Obstet Gynecol 2013, 122(2 Pt 1):406-416.
45. Russell M.A., Phipps M.G., Olson C.L., Welch H.G., Carpenter M.W. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006, 108(6):1456-1462.
46. Metzger B.E., Buchanan T.A., Coustan D.R., et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(suppl 2):S251-S260.
47. Services USDoHaH The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General: Secondhand Smoke: What it Means to You 2006, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
48. Smith S.C., Benjamin E.J., Bonow R.O., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011, 58(23):2432-2446.
49. Committee opinion no.471 Smoking cessation during pregnancy. Obstet Gynecol 2010, 116(5):1241-1244.
50. U.S. Preventive Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: clinical summary. AHRQ Publication No. 09-05131-EF-2. ; 2009. http://www.uspreventiveservicestaskforce.org/uspstf09/tobacco/tobaccosum2.htm.
51. Smith S.C., Benjamin E.J., Bonow R.O., et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011, 124(22):2458-2473.
52. Eckel R.H., Jakicic J.M., Ard J.D., et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2960-2984.
53. Eckel R.H., Jakicic J.M., Ard J.D., et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(25 suppl 2):S76-S99.
54. Sattelmair J., Pertman J., Ding E.L., Kohl H.W., Haskell W., Lee I.M. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011, 124(7):789-795.
55. Shiroma E.J., Lee I.M. Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 2010, 122(7):743-752.
56. Wenger N.K. Prevention of cardiovascular disease: highlights for the clinician of the 2013 American College of Cardiology/American Heart Association Guidelines. Clin Cardiol 2014, 37(4):239-251.
57. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336(16):1117-1124.
58. Bibbins-Domingo K. The institute of medicine report sodium intake in populations: assessment of evidence: summary of primary findings and implications for clinicians. JAMA Intern Med 2014, 174(1):136-137.
59. Jensen M.D., Ryan D.H., Apovian C.M., et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014, 129(25 Suppl 2):S102-S138.
60. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. J Am Med Assoc 2010, 303(3):235-241.
61. Prospective Studies C., Whitlock G., Lewington S., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373(9669):1083-1096.
62. Wenger N.K. Prevention of cardiovascular disease: highlights for the clinician of the 2013 American College of Cardiology/American Heart Association guidelines. Clin Cardiol 2014, 37(4):239-251.
63. Jensen M.D., Ryan D.H., Apovian C.M., et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014, 63(25 Pt B):2985-3023.
64. Schmiegelow M.D., Andersson C., Kober L., et al. Prepregnancy obesity and associations with stroke and myocardial infarction in women in the years after childbirth: a nationwide cohort study. Circulation 2014, 129(3):330-337.
65. Albert M.A., Glynn R.J., Buring J., Ridker P.M. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006, 114(24):2619-2626.
66. Jeffery R.W., Forster J.L., Folsom A.R., Luepker R.V., Jacobs D.R., Blackburn H. The relationship between social status and body mass index in the Minnesota Heart Health Program. Int J Obes 1989, 13(1):59-67.
67. Mosca L., Linfante A.H., Benjamin E.J., et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005, 111(4):499-510.
68. Young B., Hacker M.R., Rana S. Physicians's knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy 2012, 31(1):50-58.
69. Pasternak R.C., Abrams J., Greenland P., Smaha L.A., Wilson P.W., Houston-Miller N. 34th Bethesda Conference: Task force #1-identification of coronary heart disease risk: is there a detection gap?. J Am Coll Cardiol 2003, 41(11):1863-1874.
70. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. J Am Med Assoc 2007, 297(6):611-619.
71. Stuart J.J., Bairey Merz C.N., Berga S.L., et al. Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt) 2013, 22(1):37-47.
72. Executive summary: standards of medical care in diabetes-2014. Diabetes Care 2014, 37(suppl 1):S5-S13.
73. Artal R., O'Toole M. Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br J Sports Med 2003, 37(1):6-12. [discussion 12].
74. Stone N.J., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(25 Suppl 2):S46-S48.